Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX) declared a quarterly cash dividend of $0.66 per share, payable on October 19, 2022. Shareholders of record on October 4, 2022 will receive this dividend, reflecting the company's commitment to returning value to its investors. Quest Diagnostics continues to lead in diagnostic information services, supporting health outcomes with insights derived from its extensive database. This dividend announcement indicates confidence in ongoing business performance and the company's financial health.
- Declared quarterly cash dividend of $0.66 per share.
- Dividend payable on October 19, 2022, showing commitment to shareholder returns.
- Continues to lead in diagnostic information services.
- None.
SECAUCUS, N.J., Aug. 10, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-301603825.html
SOURCE Quest Diagnostics
FAQ
What is the dividend amount declared by Quest Diagnostics?
When will the dividend be paid to shareholders?
What is the record date for receiving the dividend?